LAT010

· Latticon Antibody Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAT010, covering 2025-07-08 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1) [Phase 1, Phase 2]

See pricing